Presbyopia Clinical Trial
Official title:
30 Day Trial Fitting of a New Bifocal Contact Lens
NCT number | NCT04437732 |
Other study ID # | LEN-002 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 11, 2019 |
Est. completion date | June 9, 2021 |
Verified date | January 2022 |
Source | Lentechs, LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this study, you will wear an invesetigational contact lens, Apioc-P or Apioc-PT, the way you wear your current contact lenses for approximately one month (no more than 35 days).
Status | Completed |
Enrollment | 49 |
Est. completion date | June 9, 2021 |
Est. primary completion date | June 9, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 70 Years |
Eligibility | Inclusion Criteria: 1. The subject must provide written informed consent. 2. The subject must appear willing and able to adhere to the instructions set forth in this protocol. 3. At least 40 years of age and no more than 70 years of age. 4. = 4.00 D of corneal astigmatism. 5. = 4.00 D of refractive astigmatism. 6. Refractive error range +20.00 DS to -20.00 DS 7. Keratometry readings within 40 to 50D. 8. Clear, healthy corneas with no irregular astigmatism. 9. Normal, healthy conjunctiva in both eyes. 10. Free of active ocular disease. Refractive error and presbyopia are permitted. 11. Be a current or former (within the last 12 months) contact lens wearer. 12. Best-corrected near and distance visual acuity better than or equal to 20/25. Exclusion Criteria: 1. Irregular corneal astigmatism. 2. Corneal scarring unless off line-of-site and well healed. 3. Pinguecula, pterygium, or other conjunctival thickness abnormalities that would interfere with soft contact lens wear. 4. Recent use of any ocular pharmaceutical treatments, including daily artificial tears, in the two weeks prior to the examination. Use of artificial tears less than 3 times per week is permitted. 5. Systemic disease that would interfere with contact lens wear. 6. Currently pregnant or lactating (by self-report). 7. History of strabismus or eye movement disorder, including exophoria at near that is 4D or greater than at far, and a receded near point of convergence break that is 6 cm or greater. 8. Active allergies that may inhibit contact lens wear. 9. Upper eyelid margin at or above the superior limbus. 10. History of ocular or lid surgery. |
Country | Name | City | State |
---|---|---|---|
United States | Quinn Foster & Associates | Athens | Ohio |
United States | EyeCare Professionals of Powell | Powell | Ohio |
Lead Sponsor | Collaborator |
---|---|
Lentechs, LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual Acuity | LogMAR visual acuity | 30 days | |
Secondary | Comfort | Contact Lens Dry Eye Questionnaire-8, scale range 0 minimum (better outcome) to 38 maximum (worse outcome). | 30 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05326607 -
Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia
|
N/A | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Completed |
NCT05495971 -
Extended Depth of Focus Contact Lenses for Presbyopia
|
N/A | |
Completed |
NCT05464732 -
Vivity IOL: Emmetropia Compared to Monovision.
|
N/A | |
Recruiting |
NCT06045299 -
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
|
Phase 3 | |
Active, not recruiting |
NCT04151550 -
Safety & Efficacy of the Laser Scleral Microporation Procedure (Philippines)
|
N/A | |
Not yet recruiting |
NCT05506553 -
Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision
|
N/A | |
Completed |
NCT02554396 -
Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
|
Phase 2 | |
Completed |
NCT02214797 -
Dispensing Study to Assess Visual Performance of Prototype Contact Lenses
|
N/A | |
Completed |
NCT02235831 -
DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance
|
N/A | |
Enrolling by invitation |
NCT01443585 -
Clinical Evaluation of a Progressive Addition Lens (PAL)
|
N/A | |
Completed |
NCT01591499 -
Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal
|
N/A | |
Completed |
NCT04983589 -
A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
|
Phase 3 | |
Completed |
NCT02740010 -
The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
|
||
Recruiting |
NCT05796453 -
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
|
N/A | |
Completed |
NCT02516306 -
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
|
Phase 1/Phase 2 | |
Completed |
NCT05359380 -
The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
|
||
Not yet recruiting |
NCT04522427 -
Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery
|
N/A | |
Completed |
NCT03688425 -
Comparison of Clinical Outcomes POD L GF vs POD F GF in Asian Eyes
|
N/A | |
Recruiting |
NCT06053463 -
Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers
|
N/A |